Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tristan Barber

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Infectious Diseases|December 17, 2013
'Gay bowel syndrome': relic or real (and returning) phenomenon?Farhad Cooper, Tristan Barber
British Journal of Hospital Medicine (London, England : 2005)|July 5, 2022
Managing frailty in people with human immunodeficiency virusClare Bristow, Tristan Barber
The Journal of Infection|June 17, 2008
New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonistsAmelia Hughes, Tristan Barber, Mark Nelson
Journal of the International AIDS Society|November 15, 2014
The effect of tenofovir on renal function in HIV-positive pregnant womenStuart Flanagan, Lynne Barnes, Jane Anderson, et al.
AIDS Care|March 16, 2017
Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?Sarah Parry, Sarah Zetler, Alice Kentridge, et al.
Journal of the International AIDS Society|November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitorTristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.
The Lancet. HIV|February 26, 2022
How health systems can adapt to a population ageing with HIV and comorbid diseaseJepchirchir Kiplagat, Dan N Tran, Tristan Barber, et al.
HIV Clinical Trials|March 18, 2015
The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of ageJaime H Vera, Akil Jackson, Laura Dickinson, et al.
International Journal of STD & AIDS|September 21, 2017
Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UKLauren Bull, Pavle Dimitrijevic, Sophie Beverley, et al.
Antiviral Therapy|March 23, 2013
HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroupsAnton Pozniak, Simon Rackstraw, Jane Deayton, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Infectious Diseases|December 17, 2013
'Gay bowel syndrome': relic or real (and returning) phenomenon?Farhad Cooper, Tristan Barber
British Journal of Hospital Medicine (London, England : 2005)|July 5, 2022
Managing frailty in people with human immunodeficiency virusClare Bristow, Tristan Barber
The Journal of Infection|June 17, 2008
New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonistsAmelia Hughes, Tristan Barber, Mark Nelson
Journal of the International AIDS Society|November 15, 2014
The effect of tenofovir on renal function in HIV-positive pregnant womenStuart Flanagan, Lynne Barnes, Jane Anderson, et al.
AIDS Care|March 16, 2017
Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?Sarah Parry, Sarah Zetler, Alice Kentridge, et al.
Journal of the International AIDS Society|November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitorTristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.
The Lancet. HIV|February 26, 2022
How health systems can adapt to a population ageing with HIV and comorbid diseaseJepchirchir Kiplagat, Dan N Tran, Tristan Barber, et al.
HIV Clinical Trials|March 18, 2015
The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of ageJaime H Vera, Akil Jackson, Laura Dickinson, et al.
International Journal of STD & AIDS|September 21, 2017
Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UKLauren Bull, Pavle Dimitrijevic, Sophie Beverley, et al.
Antiviral Therapy|March 23, 2013
HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroupsAnton Pozniak, Simon Rackstraw, Jane Deayton, et al.
Pageof 2